resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],The sNF96.2 cell line was derived from a recurrent mass associated with nerve tissue and diagnosed as MPNST in an NF1 patient. It has an abnormal karyotype and complete loss of heterozygosity with no detectable wild-type NF1 allele.,"['Cell line origin', 'Genomics']",,,,https://doi.org/10.4137/TOG.S8830
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"The sNF96.2 cell line exhibited increased levels of phosphorylated Erk1/2 compared to a normal cell line, indicating increased MAPK activity.",['Signaling pathway'],,,,https://doi.org/10.4137/TOG.S8830
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"In a xenograft study, the sNF96.2 cell line showed increased growth in response to estrogen treatment, especially in an Nf1 heterozygous background, compared to placebo. Progesterone inhibited its growth compared to placebo.","['Tumor growth', 'Hormone response']",,,,https://doi.org/10.4161/cbt.10.8.12878
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"The sNF96.2 cell line was cultured in DMEM medium supplemented with 10% fetal bovine serum, maintained at 37Â°C and 5% CO2.",['Cell culture conditions'],,,,https://doi.org/10.18632/oncotarget.25181
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"The cell line identity and STR profile of sNF96.2 was authenticated, showing a 100% match to the known STR profile in the ATCC database.",['Cell line authentication'],,,,https://doi.org/10.18632/oncotarget.25181
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],The sNF96.2 cell line was used in a study to analyze the effects of single agent drugs and drug combinations on cell viability.,['Drug screening'],,,,https://doi.org/10.18632/oncotarget.25181
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"The sNF96.2 cell line exhibited a very weak full-length NF1 protein band compared to normal cells, indicating severely reduced neurofibromin expression.",['Protein expression'],,,,https://doi.org/10.4137/TOG.S8830
c9a87975-378b-4930-8fda-e5896c42c86c,sNF96.2,['Cell Line'],"In a study comparing MAPK activity across MPNST cell lines, sNF96.2 showed relatively higher levels of phosphorylated Erk2 compared to phospho-Erk1.",['Signaling pathway'],,,,https://doi.org/10.4137/TOG.S8830
